![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Bispecific Antibodies in DLBCL
1. What is bispecific antibodies and how are they used to treat DLBCL? Video
2. What are key targets of bispecific antibodies in DLBCL treatment? Video
3. How do bispecifics differ from CAR-T cell therapy in terms of effectiveness and side effects? Video
4. Which drugs are FDA approved for bispecific therapy and how do they work? Video
5. What are the common side effects of bispecific therapy and how are they managed? Video
6. When are bispecific antibodies and CAR T-cell therapy used for DLBCL, and how might that change in the future? Video
What are key targets of bispecific antibodies in DLBCL treatment?
Last year
Lesson Description
This video will cover the targets on the DLBCL cells that researchers can target using bispecific antibodies.